Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLAMMAGE: Age Impact on Adaptive Immunity in RSV Infection
NCT03728413Completed
- Sponsor
- Imperial College London
- Start
- Nov 2018
- Primary completion
- May 2023
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Open-label, single-arm trial of RSV A Memphis 37 in respiratory syncytial virus infection (RSV), sponsored by Imperial College London. Primary endpoint: Number of Participants With Challenge-related Adverse Events at 180 days. Started Nov 2018; status: completed.
02
Drugs
RSV A Memphis 37
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT03728413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03728413.